Inventor
ROGERS BRUCE N
US25 patents
⚠️ This page may combine multiple inventors who share the name “ROGERS BRUCE N”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MORPHIC THERAPEUTIC INC
17 patentsUS11827621B2Nov 28, 2023
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC5 citations85
US11795167B2Oct 24, 2023
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC5 citations85
US11739087B2Aug 29, 2023
Inhibiting (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC5 citations84
US11046685B2Jun 29, 2021
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC8 citations83
US11046669B2Jun 29, 2021
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC8 citations83
US11040955B2Jun 22, 2021
Inhibitors of (alpha-v)(beta-6) integrin
MORPHIC THERAPEUTIC INC8 citations83
US10759756B2Sep 1, 2020
Antagonists of human integrin α4β7
MORPHIC THERAPEUTIC INC7 citations83
US11021480B2Jun 1, 2021
Inhibiting (α-V)(β-6) integrin
MORPHIC THERAPEUTIC INC8 citations82
US12415796B2Sep 16, 2025
Inhibitors of (αv)(β6) integrin
MORPHIC THERAPEUTIC INC2 citations74
US12145935B2Nov 19, 2024
Inhibitors of (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC4 citations74
US11174228B2Nov 16, 2021
Antagonists of human integrin (α4)(β7)
MORPHIC THERAPEUTIC INC1 citations72
US11370773B1Jun 28, 2022
Inhibiting human integrin (alpha-4) (beta-7)
MORPHIC THERAPEUTIC INC2 citations71
US12528803B2Jan 20, 2026
Inhibitors of αvβ6 integrin
MORPHIC THERAPEUTIC INC0 citations61
US12459942B2Nov 4, 2025
Inhibiting (α-v)(β-6) integrin
MORPHIC THERAPEUTIC INC0 citations61
US12221416B2Feb 11, 2025
Antagonists of human integrin α4β7
MORPHIC THERAPEUTIC INC0 citations61
US11104661B1Aug 31, 2021
Inhibiting human integrin (α-4) (β-7)
MORPHIC THERAPEUTIC INC1 citations60
US12552786B2Feb 17, 2026
Inhibitors of αvβ6 integrin
MORPHIC THERAPEUTIC INC0 citations50
UPJOHN CO
5 patentsUS6500840B2Dec 31, 2002
Quinuclidine-substituted heteroaryl moieties for treatment of disease
UPJOHN CO66 citations95
US6492385B2Dec 10, 2002
Quinuclidine-substituted heteroaryl moieties for treatment of disease
UPJOHN CO70 citations95
US6407092B1Jun 18, 2002
Tetracyclic azepinoindole compounds
UPJOHN CO110 citations95
US6599916B2Jul 29, 2003
Quinuclidine-substituted heteroaryl moieties for treatment of disease
UPJOHN CO53 citations92
US6562816B2May 13, 2003
Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
UPJOHN CO26 citations92
PFIZER
3 patentsUS6919359B2Jul 19, 2005
Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
PFIZER61 citations95
US6875762B2Apr 5, 2005
Tetracyclic azepinoindole compounds
PFIZER15 citations82
US6858613B2Feb 22, 2005
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
PFIZER5 citations62